Omalizumab, sold under the brand name Xolair among others, is an injectable medication to treat severe persistent allergic forms of asthma, nasal polyps...
47 KB (4,925 words) - 23:04, 16 August 2024
Pharmacotherapy (section Example: Omalizumab Therapy)
in allergic reactions. The efficacy of omalizumab may vary among patients. To identify responders to omalizumab, the level of several biomarkers can be...
28 KB (3,050 words) - 12:24, 6 August 2024
includes the use of antihistamines, corticosteroids, monoclonal antibodies (omalizumab), and in some cases, immunosuppressive drugs. Despite ongoing research...
35 KB (3,673 words) - 06:34, 15 January 2024
control. Experimentally, a low dose of methotrexate or cyclosporin and omalizumab (a monoclonal anti-IgE antibody) has been used. Treatment of autoimmune...
21 KB (1,860 words) - 00:23, 8 September 2024
phase I to IV clinical trials of omalizumab in various indications, concluded that a causal relationship between omalizumab therapy and malignancy is unlikely...
28 KB (3,269 words) - 02:35, 27 September 2024
long term antihistamine therapy is indicated. Immunosuppressants such as omalizumab or cyclosporin may also be used. About 20% of people are affected at some...
50 KB (5,739 words) - 08:07, 14 September 2024
off-label therapy with cyclosporine A or montelukast or add-on therapy with omalizumab, which is an approved treatment option for CSU. Angioedema, excruciatingly...
47 KB (4,686 words) - 02:02, 7 September 2024
avoid food allergies, azathioprine and antibodies, including mepolizumab, omalizumab, infliximab, and adalimumab. The word enteritis (/ˌɛntəˈraɪtɪs/) uses...
19 KB (1,905 words) - 05:45, 25 September 2024
have dangerous reactions to these drugs Monoclonal antibodies, such as omalizumab Corticosteroids The prognosis of MCAS is uncertain. The condition was...
21 KB (2,096 words) - 18:42, 28 August 2024
cells and thereby help prevent acute rejection of kidney transplants. Omalizumab inhibits human immunoglobulin E (IgE) and is useful in treating moderate-to-severe...
49 KB (4,964 words) - 09:59, 20 September 2024
CU is rather limited in most cases. Treatment(s) with mixed success: omalizumab (anti-IgE therapy), danazol (synthetic androgen), propranolol (beta blocker)...
17 KB (1,707 words) - 05:15, 6 July 2024
to OIT to reduce immune response. In 1 trial, the monoclonal antibody omalizumab was combined with high-dose milk oral immunotherapy and saw positive results...
31 KB (3,504 words) - 18:39, 3 July 2024
marboxil), for influenza A and B (both treatment and prevention). Xolair (omalizumab), for asthma, chronic idiopathic urticaria (CIU), and nasal polyps. Zelboraf...
57 KB (5,180 words) - 21:47, 26 September 2024
Food allergy (section Omalizumab)
have generally been used to treat peanut and environmental allergies. Omalizumab, an injectable asthma treatment drug sold under the brand name Xolair...
112 KB (12,197 words) - 18:12, 24 July 2024
as of December 2021. Subcutaneous injection of the anti-IgE antibody omalizumab is being studied as a method of preventing recurrence, but it is not yet...
58 KB (6,226 words) - 03:59, 9 September 2024
International Nonproprietary Names of humanized antibodies end in -zumab, as in omalizumab (see Nomenclature of monoclonal antibodies). Humanized antibodies are...
14 KB (1,787 words) - 23:05, 9 January 2024
Twinject) for use in the event of a serious reaction. Studies have found that omalizumab (Xolair) may be an effective and safe treatment for cold urticaria in...
23 KB (2,552 words) - 15:57, 21 September 2024
approaches to reducing autumn exacerbations, but while costly, seasonal omalizumab treatment from four to six weeks before school return may reduce autumn...
167 KB (18,030 words) - 09:27, 19 September 2024
medicine in asthma and food allergies. Umetsu's research has shown that omalizumab, an anti-IgE monoclonal antibody, marketed as Xolair by Genentech, can...
8 KB (659 words) - 11:16, 23 August 2024
Prevention of bone fractures in cancer patients 1,288 2012 −13% Xolair (omalizumab) Moderate-to-severe asthma not controlled by inhaled steroids Chronic...
144 KB (12,145 words) - 21:14, 28 September 2024
Rachid R, Gragg H, Little SV, Lakin P, Cianferoni A, et al. (March 2017). "Omalizumab facilitates rapid oral desensitization for peanut allergy". The Journal...
59 KB (6,128 words) - 05:06, 8 July 2024
has been shown to reduce viral load and pro-inflammatory IL-1β in mice. Omalizumab, which was developed for treatment of severe allergic asthma, has shown...
30 KB (3,474 words) - 23:00, 28 August 2024
"Clot-busting" drug to treat acute myocardial infarction. 2003: Xolair (omalizumab): Subcutaneous injection for moderate to severe persistent asthma. 2003:...
32 KB (2,862 words) - 04:08, 6 August 2024
mycophenolate, and azathioprine. Newer targeted medications, including omalizumab and belimumab, have also been used. Urticarial vasculitis is featured...
6 KB (715 words) - 07:24, 4 August 2023
pegol Mepolizumab Mogamulizumab Natalizumab Ocrelizumab (+hyaluronidase) Omalizumab Ozoralizumab Pascolizumab Pateclizumab Pembrolizumab Pexelizumab Pidilizumab...
38 KB (4,316 words) - 10:24, 26 August 2024
treatment options with oral corticosteroids, biological treatments (e.g. omalizumab, mepolizumab) or allergen immunotherapy. Eczema Asthma Rhinitis Anaphylaxis...
24 KB (2,561 words) - 17:54, 7 July 2024
asthma symptomatic control include omalizumab, mepolizumab, reslizumab, benralizumab, dupilumab and tezepelumab. Omalizumab binds to free human immunoglobulin...
26 KB (2,749 words) - 01:59, 28 July 2024
275–292. Zirbes JM, Milla CE (June 2008). "Steroid-sparing effect of omalizumab for allergic bronchopulmonary aspergillosis and cystic fibrosis". Pediatric...
34 KB (3,380 words) - 03:33, 5 August 2024
et al. (2008). "Conversion of cetuximab, panitumumab, trastuzumab and omalizumab into T-cell-engaging BiTE antibodies creates novel drug candidates of...
9 KB (1,472 words) - 21:30, 9 September 2024
emerging targeted biotherapies—including the anti-IgE monoclonal antibody omalizumab, immunomodulation with Interferon-α, and B cell therapy with rituximab—may...
28 KB (2,682 words) - 19:53, 23 August 2024